New starch-based radiotracer for lung perfusion scintigraphy

Purpose In order to avoid the microbiological risks linked to human serum albumin macroaggregates (MAA) used for lung perfusion scintigraphy, we developed a new starch-based Tc-99m potential radiopharmaceutical. Methods Microparticles were prepared from oxidised starch coupled to natural polyamine f...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of nuclear medicine and molecular imaging Vol. 37; no. 1; pp. 146 - 155
Main Authors Lacoeuille, Franck, Hindré, François, Denizot, Benoit, Bouchet, Francis, Legras, Pierre, Couturier, Olivier, Askiénazy, Serge, Benoit, Jean Pierre, Le Jeune, Jean Jacques
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer-Verlag 2010
Springer Nature B.V
Springer Verlag (Germany) [1976-....]
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Purpose In order to avoid the microbiological risks linked to human serum albumin macroaggregates (MAA) used for lung perfusion scintigraphy, we developed a new starch-based Tc-99m potential radiopharmaceutical. Methods Microparticles were prepared from oxidised starch coupled to natural polyamine for Tc-99m complexation. Suspensions were formulated as ready-to-use kits for easy one-step labelling procedures. Results Particle-size analysis, electron microscopy, and confocal microscopy were performed for microparticle characterisation, and gave a typical size distribution ranging from 7 to 63 µm, with a homogenous population of spherical or oval-shaped microparticles. Radiochemical purity exceeded 95%, and was stable for at least 8 h. When challenged with histidine and human plasma, labelling was also stable. Dynamic scintigraphic acquisitions and biodistribution studies conducted on healthy Wistar rats showed a tracer accumulation with more than 80% of the ID in the lungs after 15 min. Conclusions With clinically significant characteristics such as a lung half-life of 3 h, a lung-to-vascular ratio of 900, and a lung-to-liver ratio of 90, starch-based microparticles exhibit all the qualities for an effective new lung perfusion agent.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:1619-7070
1619-7089
DOI:10.1007/s00259-009-1226-6